Study Evaluating LXR-623 in Healthy Japanese Adults

Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of LXR-623 Administered Orally to Healthy Japanese Male Subjects.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00385489

Enrollment

Unknown

Registered

2006-10-09

Start date

2006-08-31

Completion date

2006-09-30

Last updated

2009-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The purpose of this study is to evaluate the safety of LXR-623 in healthy Japanese subjects.

Interventions

DRUGLXR-623

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

MALE

Age

20 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* Healthy, Japanese Males aged 20-45 years

Exclusion criteria

* A history or active presence of clinically important medical disease

Design outcomes

Primary

Measure	Time frame
Safety	—

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026